NYSE · EPC
Consumer Defensive · Household & Personal Products
$27.95▼ 0.39% ($0.11)at close
As of 4:00 PM ET
Valuation
Verdict: fairly priced. Price between Bear and Base.
The price holds with free cash flow shrinking 17.0% a year for 5 years. Our scenarios assume −24.4–5.6%.
Its past 10 years averaged −9.4% a year.
Value per share
Base case
$51.31
Price used $27.95 is 46% below this
USD · TTM ending Jun 30, 2026 · Price Oct 26, 8:00 PM UTC
Effective tax rate could not be derived — using 21% US default.
FCFF base normalized by replacing latest capex with the company's trailing median capex-to-revenue ratio.
Historical FCFF CAGR and the default growth rates are taken from the raw historical series. The valuation base is normalized for the current-period DCF.
Market beta (0.40) is below the minimum default of 0.5 — short lookback windows can understate systematic risk. Beta floored at 0.5 for default assumptions; adjust manually if needed.
Free cash flow each value needs
Free cash flow today $142M. The price needs $66.8M by 2036. Base case: $103M. At its recent pace: $53.2M. Bear to Bull: $41.8M to $222M.
$66.8M
What the price needs
−17.0% a year for 5 yrs · by 2036
$53.2M
At its recent pace
−9.4% a year
−$36.6M
less free cash flow in 2036 than the Base case expects
$103M
Base case → $51.31/share
Free cash flow today $142M. The price needs $66.8M by 2036. Base case: $103M. At its recent pace: $53.2M. Bear to Bull: $41.8M to $222M.
Free cash flow in 2036
today $142M
−$36.6Mless than the Base case
Value per share · Base case
$51.31
Price $27.95
46% below this
Effective tax rate could not be derived — using 21% US default.
FCFF base normalized by replacing latest capex with the company's trailing median capex-to-revenue ratio.
Historical FCFF CAGR and the default growth rates are taken from the raw historical series. The valuation base is normalized for the current-period DCF.
Market beta (0.40) is below the minimum default of 0.5 — short lookback windows can understate systematic risk. Beta floored at 0.5 for default assumptions; adjust manually if needed.
USD · TTM ending Jun 30, 2026 · Price Oct 26, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
The stock rose 43.04% over the last year. Revenue declined 7% over the trailing twelve months. Operating margin moved from 6.96% to 1.66%. Free cash flow grew 22.72% over the trailing twelve months.
The stock is rising despite deteriorating fundamentals and now sits at the 87th percentile of its historical P/FCF range. This is a momentum-driven move — the market may be front-running a recovery that has not yet appeared in reported numbers.
Operating margin (currently 1.66%) would need to stabilize or improve to justify the move. Revenue is declining 7% — a trend reversal in the next report would be the key signal to watch. This read is wrong if the next period shows operating metrics turning the corner. At that point the price would be anticipating real improvement rather than running ahead of it.
Company profile
Edgewell Personal Care Company, along with its associated businesses, is a global producer and distributor of a diverse range of personal care items.
Market multiples
Stock splits
Every 1000 shares became 1349
Profitability & growth
Analyst consensus
6
Buy
11
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 12, 2026
Q4 FY26 · EPS est $0.77 · Revenue est $479.9M
Same quarter, year over year
FY26 YTD -37.6%Each cell vs the same quarter a year earlier (the cell below) · Q1–Q3 combined $1.16 vs $1.86 · 0 of 3 quarters up
Q1
Q2
Q3
Q4
FY total
FY26
—
FY25
FY24
FY23
—
—
—
—
Fiscal year totals
n/m: last year’s figure was zero, a loss or too small to compare against
Q3 FY26
Reported Aug 5, 2026 · Latest
HoverTap a cell to inspect
Actual
$0.72
Estimate
$0.65
Year over year
-21.7%
Vs prior quarter
+20.0%
Edgewell Personal Care Company · EPC
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.
Market cap
$1.29B
P/E
N/M
EPS (TTM)
-$2.00
Next earnings
Nov 12, 2026